Redsense Medical AB (XSAT:REDS) Total Operating Expense: kr21.63 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:REDS Redsense Medical AB XSAT:REDS
54 GF Score
Price kr4.42
GF Value kr6.86
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Redsense Medical AB Total Operating Expense?

Redsense Medical AB XSAT:REDS +2.79% 54 Total Operating Expense is kr21.63 Mil as of Mar. 2026. GuruFocus rates XSAT:REDS with a GF Score™ of 54/100 and a GF Value™ of kr6.86 (Possible Value Trap). The stock has 5 warning signs investors should review.

Redsense Medical AB's Total Operating Expense for the three months ended in Mar. 2026 was kr4.18 Mil. Redsense Medical AB's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was kr21.63 Mil.

Redsense Medical AB Total Operating Expense Related Terms

Redsense Medical AB Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Redsense Medical AB's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Redsense Medical AB Total Operating Expense Chart

Redsense Medical AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.39 21.47 18.20 17.87 22.93

Redsense Medical AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.48 5.98 4.74 6.72 4.18
XSAT:REDS
54GF Score
Redsense Medical AB XSAT:REDS
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Redsense Medical AB Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr21.63 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of kr21.63 Mil mean?
Redsense Medical AB (XSAT:REDS) has a Total Operating Expense of kr21.63 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Redsense Medical AB and its competitors.
Is Redsense Medical AB's Total Operating Expense too high?
Redsense Medical AB's current Total Operating Expense is kr21.63 Mil. Overall, Redsense Medical AB has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Redsense Medical AB's Total Operating Expense compare to ABT and SYK?
Redsense Medical AB's Total Operating Expense of kr21.63 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Redsense Medical AB and its competitors. Redsense Medical AB's current Total Operating Expense is kr21.63 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redsense Medical AB stock overvalued right now?
Based on GuruFocus' analysis, Redsense Medical AB (XSAT:REDS) is currently considered Possible Value Trap. The stock's GF Value™ is kr6.86, compared to a current price of kr4.42 — trading 35.6% below its estimated fair value. The current Total Operating Expense is kr21.63 Mil. Redsense Medical AB's overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Redsense Medical AB (XSAT:REDS), the current Total Operating Expense is kr21.63 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Redsense Medical AB (XSAT:REDS) Overvalued in 2026?

Based on GuruFocus' analysis, Redsense Medical AB stock appears to be undervalued. The current stock price of kr4.42 is trading 35.6% below its estimated GF Value™ of kr6.86. GuruFocus considers Redsense Medical AB to be Possible Value Trap.

Key valuation signals for XSAT:REDS:

  • Total Operating Expense: kr21.63 Mil
  • GF Value™: kr6.86 vs. price of kr4.42 (35.6% below fair value)
  • GF Score™: 54/100 with 5 warning signs

No single metric tells the full story. See the XSAT:REDS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Redsense Medical AB Business Description

Address Storgatan 36, Halmstad, SWE, 302 43
Redsense Medical AB manufactures and sells blood loss detection devices in Sweden. The company has developed a monitoring system that can detect the first sign of a blood leak using patented fiber optic technology. The products of the company include Alarm Unit, Venous Needle Patch, Sensor Patch, and others.
54GF Score

Get the complete analysis for XSAT:REDS

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr4.42
Price
kr6.86
GF Value